Since the SHH pathway plays a critical role in the renewal of CSCs, blockade of SHH pathway has evolved as a promising therapy for various types of cancers including lung cancer (Savani et al. 2012; Kieran 2014). This evidence concerns the gene SHH and lung carcinoma.